Monitoring of minimal residual disease after CHOP and rituximab in previously untreated patients with follicular lymphoma.
Rambaldi A, Lazzari M, Manzoni C, Carlotti E, Arcaini L, Baccarani M, Barbui T, Bernasconi C, Dastoli G, Fuga G, Gamba E, Gargantini L, Gattei V, Lauria F, Lazzarino M, Mandelli F, Morra E, Pulsoni A, Ribersani M, Rossi-Ferrini PL, Rupolo M, Tura S, Zagonel V, Zaja F, Zinzani P, Reato G, Foa R.
Rambaldi A, et al. Among authors: foa r.
Blood. 2002 Feb 1;99(3):856-62. doi: 10.1182/blood.v99.3.856.
Blood. 2002.
PMID: 11806987
Free article.
Clinical Trial.